NG2-binding peptide also known as NG2 ligand peptide, was identified using a phage-displayed peptide library. This peptide is known to bind NG2 a membrane proteoglycan, homologous to the melanoma-associated antigen. Results of additional in vitro and in vivo assays imply that NG2 ligand peptide can be used for tumor targeting.
Usually ships within 24 hours.